Home CRISPR Therapeutics

CRISPR Therapeutics

In operation
Post-IPO Round
Gene Editing Drug Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

CRISPR Therapeutics is a gene-editing company developing genetic medicines for a variety of diseases through its CRISPR/Cas9 gene-editing platform, researching treatments for cystic fibrosis, blindness, blood disorders, and congenital heart disease. CRISPR/Cas9 is a revolutionary technology that allows for direct and precise gene editing.
CRISPR Therapeutics AG
Zug,Zug,Switzerland
101~500 people
January 01, 2013
info@crisprtx.com

Enterprise Profile

Industrial Sector
Immune Cell Therapy Gene Therapy
Technology
Gene Technology Immunological Techniques Cell Technology
Concept
Lymphoma
Application Scenarios
Cell and Gene Therapy